P D Hinduja Hospital & Medical Research Centre, in association with The Division of AIDS (NIAID, NIH), recently held a two-day symposium on Advancing TB Research “ An Exploration of Opportunities in India to highlight the most pressing global and national health concern of infectious diseases, specifically TB.
More than 230 healthcare professionals, researchers, etc., from India and the US discussed innovations and solutions to address this challenge. The main objective was to bring all relevant stakeholders together to discuss challenges of TB diagnosis, drug resistance and public awareness in India, as well as discuss ways to significantly improve health outcomes for both communicable and non-communicable diseases affecting India and the world.
In order to address this growing burden of infectious diseases and facilitate strengthening of clinical research capabilities in India through concerted training and research activities, P D Hinduja Hospital & MRC will work together with The Division of AIDS (NIAID, NIH), the US Department of Health & Human Services. This was signed by Mr. Gautam Khanna, CEO, P D Hinduja Hospital & MRC and Dr Carl Dieffenbach, Director, The Division of AIDS (NIAID, NIH). This international collaboration will provide a platform to discuss and facilitate rapid transfer of knowledge to ensure the highest quality of research for the benefit of Indian population.
The key issues highlighted by the speakers were the importance of multidisciplinary approach and greater collaboration with both public and private stakeholders. Additionally, they advocated mutual learning, sharing of knowledge and global collaborations to ensure the highest quality medical research in infectious diseases, and sharing of the latest advancement in research and clinical strategies.
Overall, the symposium was a huge success where key topics, such as Optimizing Clinical Management of Tuberculosis, Clinical Pearls “ Success Story in Patient Management, etc., were discussed by the local and international speakers in the field of infectious diseases.